Quantitative assessment of hemoglobin-induced endothelial barrier dysfunction

Journal of Applied Physiology

Volumn 97, Issue 5, 2004, Pages 1930-1937

  Dull, Randal O ^a,b   DeWitt, Bracken J ^a   Dinavahi, Ramani ^a   Schwartz, Larry ^a   Hubert, Christopher ^a   Pace, Nathan ^b   Fronticelli, Clara ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Albumin; Blood substitutes; Restricted diffusion

Indexed keywords

ACTIN; ALBUMIN; BLOOD SUBSTITUTE; HEMOGLOBIN; HEMOGLOBIN A; HEMOGLOBIN BASED OXYGEN CARRIER; POLYMERIZED HEMOGLOBIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ALPHA CHAIN; ANIMAL CELL; ARTICLE; BETA CHAIN; BLOOD VESSEL PERMEABILITY; CATTLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; EXTRAVASATION; IMMUNOFLUORESCENCE; LUNG BLOOD VESSEL; MICROVASCULATURE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE;

ANIMALS; BLOOD SUBSTITUTES; CAPILLARY PERMEABILITY; CATTLE; CELLS, CULTURED; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HEMOGLOBIN A; HUMANS; LUNG; MICROCIRCULATION; POLYMERS; RECOMBINANT PROTEINS; SERUM ALBUMIN, BOVINE; STRESS FIBERS;

EID: 7044237149     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00102.2004     Document Type: Article

References (37)

1. Alayash AI. Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants? Nat Biotechnol 17: 545-549, 1999.
2. Baldwin AL. Modified hemoglobins produce venular interendothelial gap formation and albumin leakage in the rat mesentery. Am J Physiol Heart Circ Physiol 277: H650-H659, 1999.
3. 2 carriers on intestinal integrity and microvascular leakage. Am J Physiol Heart Circ Physiol 283: H1292-H1301, 2002.
4. Baldwin AL, Wiley EB, Summers AG, and Alayash AI. Sodium selenite reduces hemoglobin-induced venular leakage in the rat mesentery. Am J Physiol Heart Circ Physiol 284: H81-H91, 2003.
5. Bingaman S, Huxley VH, and Rumbaut RE. Fluorescent dyes modify properties of proteins used in microvascular research. Microcirculation 10: 221-231, 2003.
6. 2 transporter. Am J Physiol Heart Circ Physiol 285: H549-H561, 2003.
7. Caron A, Menu P, Faivre-Fiorina B, Labrude P, Alayash AI, and Vigneron C. Cardiovascular and hemorheological effects of three modified human hemoglobin solutions in hemodiluted rabbits. J Appl Physiol 86: 541-548, 1999.
8. Chang YS, Munn LL, Hillsley MV, Dull RO, Yuan J, Lakshminarayanan S, Gardner TW, Jain RJ, and Tarbell JM. Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties. Microvasc Res 59: 265-277, 2000.
9. Dudek SM and Garcia JGN. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 91: 1487-1500, 2001.
10. Dull RO, Dinavahi K, Schwartz L, Humphries DE, Berry D, Sasisekharan R, and Garcia JGN. Lung endothelial heparan sulfates mediate cationic peptide-induced barrier dysfunction: a new role for the glycocalyx. Am J Physiol Lung Cell Mol Physiol 285: L986-L995, 2003.
11. Dull RO and Garcia JGN. Leukocyte-induced microvascular permeability: how contractile tweaks lead to leaks. Circ Res 90: 1143-1144, 2002.
12. Dull RO, Jo HJ, Sill H, Hollis TM, and Tarbell JM. The effect of varying albumin concentration and hydrostatic pressure on the hydraulic conductivity and albumin permeability of cultured endothelial monolayers. Microvasc Res 41: 390-407, 1991.
13. Dull RO, Yuan J, Chang YS, Tarbell JM, Jain RK, and Munn LL. Kinetics of placenta growth factor/vascular endothelial growth factor synergy in endothelial hydraulic conductivity and proliferation. Microvasc Res 61: 203-210, 2001.
14. Fronticelli C, Arosio C, Bobofchak KM, and Vasquez GV. Molecular engineering of a polymer of tetrameric hemoglobin. Proteins 44: 212-222, 2001.
15. Fronticelli C, Bellelli A, and Brinigar WS. Approaches to the engineering of hemoglobin-based oxygen carriers. Transfus Alter Transfus Med 5: 516-520, 2004.
16. Giaever I and Keese CR. A morphological biosensor for mammalian cells. Nature 366: 591-592, 1993.
17. Gosting LG. Measurements and interpretation of diffusion coefficients of proteins. Adv Protein Chem 11: 429-554, 1956.
18. Habler OP and Messmer KF. Tissue perfusion and oxygenation with blood substitutes. Adv Drug Delivery Res 40: 171-184, 2000.
19. Harris NR, White SP, Zilberberg J, Alexander JS, and Rumbaut RE. Extravascular transport of fluorescently labeled albumins in the rat mesentery. Microcirculation 9: 177-187, 2002.
20. 19a. Hughes GS Jr, Antal EJ, Locker PK, Francome SF, Adams WJ, and Jacobs EE Jr. Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans. Crit Care Med 24: 756-764, 1996.
21. 19b. Hughes GS, Francome SF, Antal EJ, Adams WJ, Locker PK, Yancey EP, and Jacobs EE Jr. Hematological effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects. J Lab Clin Med 126: 444-451, 1995.
22. Jo HJ, Dull RO, Hollis TM, and Tarbell JM. Endothelial albumin permeability is shear-dependent, time-dependent and reversible. Am J Physiol Heart Circ Physiol 260: H1992-H1996, 1991.
23. Kavdia M, Pittman RN, and Popel AS. Theoretical analysis of effects of blood substitute affinity and cooperativity on organ oxygen transport. J Appl Physiol 93: 2122-2128, 2002.
24. 2 carriers. Microvasc Res 66: 49-58, 2003.
25. Kavdia M, Tsoukias NM, and Popel AS. Model of nitric oxide diffusion in arterioles: impact of hemoglobin-based blood substitutes. Am J Physiol Heart Circ Physiol 282: H2245-H2253, 2002.
26. Kjellstrom BT. Blood substitutes: where do we go from here? J Intern Med 253: 495-497, 2003.
27. Matheson B, Kwansa HE, Bucci E, Rebel A, and Kohler RC. Vascular response to infusions of a non-extravasating hemoglobin polymer. J Appl Physiol 93: 1479-1486, 2002.
28. Moore EE. Blood substitutes: the future is now. J Am Coll Surg 196: 1-17, 2003.
29. Nakai K, Sakuam I, Ohta T, Ando J, Kitabatake A, Nakazato Y, and Takahashi TA. Permeability characteristics of hemoglobin derivatives across cultured endothelial monolayers. J Lab Clin Med 132: 313-319, 1998.
30. Rohlfs RJ, Bruner E, Chiu A, Gonzales ML, Magder D, Magde MD, Vandegriff KD, and Winslow RM. Arterial blood pressure response to cell-free hemoglobin solutions and the reaction with nitric oxide. J Biol Chem 273: 12128-12134, 1998.
31. Rumbaut RE, Harris NR, Sial AJ, Huxley VH, and Granger DN. Leakage response to L-NAME differ with fluorescent dye used to label albumin. Am J Physiol Heart Circ Physiol 276: H333-H339, 1999.
32. Rumbaut RE and Sial AJ. Differential photoxicity of fluorescent dye-labeled albumin conjugates. Microcirculation 6: 205-213, 1999.
33. 2 carriers determine constriction of resistance arteries and hypertension. Am J Physiol Heart Circ Physiol 279: H908-H915, 2000.
34. 2 therapeutics. Am J Physiol Heart Circ Physiol 285: H1411-H1419, 2003.
35. Winslow RM. Blood substitutes: refocusing an elusive goal. Br J Haematol 111: 387-396, 2000.
36. Winslow MM, Gonzales A, Madge M, McCarthy M, Rohlfs RJ, and Vandegriff KD. Vascular resistance and the efficacy of red cell substitute in a rat hemorrhage model. J Appl Physiol 85: 993-1003, 1998.
37. Yeh LH and Alayash AI. Redox side reactions of haemoglobin and cell signaling mechanisms. J Intern Med 253: 518-526, 2003.